Fraser ($SGX:F99) and Neave Holdings, commonly known as F&N, reported a slight increase in profit attributable to owners of the parent for its fiscal Q3. This increase brought its total profit to 99.4 million ringgit. It has grown to become one of the most recognizable names in Southeast Asia, with a wide range of products such as soft drinks, beer, dairy products, and more.
It is listed on the Singapore Exchange and is a component stock of the Straits Times Index. Going forward, F&N will look to continue to grow its portfolio of products and optimize its business operations in order to achieve sustainable growth and profitability.
In its latest earning report for the quarter ended March 31 2021, FRASER AND NEAVE (F&N) reported an increase in their profits and revenue. Total revenue stood at 988.56M SGD, a slight decrease of 2.1% compared to the previous year. Net income however, saw an increase of 21.8%, coming in at 83.45M SGD.
Over the last three years, F&N’s total revenue has increased from 988.56M SGD to 1045.32M SGD. This marks a modest but positive growth for the company, which is a welcome development for shareholders.
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for F99. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for F99. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for F99. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for F99 are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
On Friday, FRASER AND NEAVE (F&N) stock opened at SG$1.1 and closed at SG$1.1, with its profit and revenue marginally increasing in the third quarter of its fiscal year. This marks an increase in the company’s overall performance, due in part to its main activities such as food and beverage production, property development, and publishing for the past financial quarter. Even though the figures are modest compared to prior years, it is encouraging to see that F&N is slowly improving. The company is continuing to pursue growth strategies that are centered around its core businesses and boost its profitability in the long run.
Furthermore, F&N has made further investments in digital capabilities, which should help to drive further growth in the near future. All in all, this latest quarterly report from F&N shows that the company is on track towards a positive trajectory, with minimal increases in profits and revenue. With continued focus on its core operations and digital investments, F&N should be able to make further gains in the coming quarters. Live Quote…
GoodWhale’s analysis of FRASER AND NEAVE’s fundamentals shows that it is a company with high health. According to our Star Chart, FRASER AND NEAVE has a score of 8/10, indicating excellent cash flows and debt management capabilities that will enable it to sustain future operations even in times of crisis. FRASER AND NEAVE’s fundamentals are strong in the area of dividends, medium in profitability and weak in the area of asset and growth. This combination of metrics classifies FRASER AND NEAVE as a ‘cow’, a type of company we believe has the track record of paying out consistent and sustainable dividends. This type of company may be particularly attractive to investor’s looking for reliable income streams. More…
Risk Rating Analysis
Star Chart Analysis
Established in 1883, Fraser and Neave Ltd has become a leader in the region, providing a wide range of products from beverages to packaged food.
– DOD Biotech PCL ($SET:DOD)
DOD Biotech PCL is a biotechnology company involved in the development and distribution of innovative healthcare products and services. With a market capitalization of 1.72 billion dollars as of 2022, the company is well-positioned to continue its growth trajectory. Furthermore, its Return on Equity stands at 3.52%, indicating the company’s efficiency and profitability. DOD Biotech has successfully developed products such as anticoagulant therapies, anti-cancer drugs, and a range of other treatments for a variety of diseases. The company focuses on innovation and customer satisfaction, and its success in these two areas has allowed it to grow into a market leader.
– Thai President Foods PCL ($SET:TFMAMA)
Thai President Foods PCL is a leading food and beverage company in Thailand. It produces and distributes a wide range of products including instant noodles, snack foods, and beverages. As of 2022, the company’s market capitalization is estimated to be around 67.26B, making it one of the largest companies in Thailand. Additionally, the company has achieved a healthy return on equity of 10.0%, indicating that it has successfully managed to generate returns on its investments. This is indicative of the company’s strong financial performance and sound business strategy.
– PT Diamond Food Indonesia Tbk ($IDX:DMND)
Diamond Food Indonesia Tbk is a leading Indonesian food and beverage company. The company offers a wide variety of products including snacks, processed foods, seasonings, beverages, and other products. As of 2022, Diamond Food Indonesia Tbk has a market capitalization of 7.48T, making it one of the largest companies in Indonesia. Its Return on Equity (ROE) of 5.19% is considered to be above the industry average, indicating that the company is efficiently utilizing its equity to generate returns.
Profit attributable to owners of the parent company rose to 99.4 million ringgit due to improved performance in its consumer, food and beverage, and publishing and printing segments. Investors should keep an eye on Fraser and Neave’s future performance, with potential investment opportunities arising from the company’s strategic efforts to diversify its portfolio and expand into new markets.